Two Phase 3 Trials of Baricitinib for Alopecia Areata

Original Article

B. King, M. Ohyama, O. Kwon, A. Zlotogorski, J. Ko, N.A. Mesinkovska, M. Hordinsky, Y. Dutronc, W.-S. Wu, J. McCollam, C. Chiasserini, G. Yu, S. Stanley, K. Holzwarth, A.M. DeLozier, and R. Sinclair

N Engl J Med 2022;386:1687-1699

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
05/04/2022
Course expires: 
05/05/2024

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation